You are here: Industry Insights > Moderna

News List

Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine americanpharmaceuticalreview
April 12, 2021
Moderna, Inc. highlighted the publication of antibody persistence data out to 6 months following the second dose of the Moderna COVID-19 Vaccine in The New England Journal of Medicine.
UK starts administering Moderna vaccine against COVID-19 expresspharma
April 08, 2021
The UK began the rollout of the Moderna vaccine to protect against COVID-19, the third two-dose vaccine now being administered by the National Health Service (NHS) alongside the Pfizer/BioNTech and Oxford/AstraZeneca jabs.
US commences research on allergic reaction risk in Moderna, Pfizer vaccines expresspharma
April 08, 2021
Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.
Moderna, Catalent Enter Long-Term Strategic Vax Pact contractpharma
April 08, 2021
Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.
Moderna gets USFDA nod for bigger vials of COVID-19 vaccine expresspharma
April 06, 2021
Moderna said its vaccine can now be supplied in vials containing 11 or 15 doses, and it expected to begin shipping 15-dose vials in coming weeks.
NIH begins trial of Moderna’s Covid-19 variant vaccine pharmaceutical-technology
April 02, 2021
The US National Institutes of Health (NIH) has initiated dosing in a new Phase I clinical trial of Moderna’s investigational vaccine candidate, mRNA-1273.351, in adult subjects.
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna worldpharmanews
March 31, 2021
EMA's human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
First ever Award for Extraordinary Impact on Health bestowed on Moderna and Pfizer europeanpharmaceuticalreview
March 31, 2021
While announcing 2021’s Top 10 Clinical Research Achievement Awards, the US Clinical Research Forum revealed that Pfizer and Moderna would be honoured for their COVID-19 vaccines.
COVID-19 vaccines from Pfizer, Moderna very effective after first shot: US real-world study expresspharma
March 31, 2021
The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found.
Moderna ships 100 millionth dose of its COVID-19 vaccine to US govt expresspharma
March 30, 2021
Moderna announced that the company has shipped the 100-millionth dose of its COVID-19 vaccine to the US Government.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page